Brief: Cellectar Biosciences To Highlight Strategic Initiatives For 2026
09/01/2026 13:33
Jan 9 (Reuters) - Cellectar Biosciences Inc CLRB.O: CELLECTAR BIOSCIENCES TO HIGHLIGHT STRATEGIC INITIATIVES FOR 2026 AT UPCOMING BIOTECH SHOWCASE DURING 44TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE Source text: ID:nGNX67DQsp Further company coverage: CLRB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellectar Biosciences
See all newsCellectar Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Cellectar Biosciences Q2 net loss widens on higher R&D costs
Cellectar Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Cellectar Biosciences Q1 net loss narrows, completes $140 mln financing
Brief: Cellectar Biosciences To Highlight Strategic Initiatives For 2026